- The Harrisonburg Daily News-Record4 days ago
- Benzinga7 days ago
Endo Health Solutions Inc. company research & investing information. Find executives and the latest company news.
Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration.
NEW YORK - Attorney General Eric T. Schneiderman today announced an agreement with Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. (“Endo”), which make and sell the long-acting opioid, Opana ER.
Shareholders of Endo Pharmaceutical Holdings voted at the company’s annual shareholder meeting Wednesday to change the company’s name to Endo Health Solutions.
Endo Health Solutions, Inc. annual report, contact information and more. Videos, webcasts, presentations and Annual Reports for more than 30,000 companies.
On Wednesday, Endo International (NASDAQ: ENDP) will release its latest earnings report. Benzinga's outlook for Endo is included in the following ...
CHADDS FORD, Pa., May 23, 2012 /PRNewswire-FirstCall/ -- Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's name to Endo Health Solutions Inc. The name change is in conjunction with the launch of Endo's ...
February 28, 2014 Response of the Office of Chief Counsel Division of Corporation Finance. Re: Endo Health Solutions Inc., Endo International Limited and Paladin Labs ...
- related to Endo Health Solutions Inc